VJHemOnc is committed to improving our service to you

ASCO 2019 | ASCO 2019: CAR-T trial highlights

VJHemOnc is committed to improving our service to you

Nirav Niranjan Shah

In this video, Nirav Niranjan Shah, MD, highlights new, exciting CAR T-cell data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting in Chicago, IL. The TRANSCEND-NHL-001 Phase I trial (NCT02631044) showed promise in mantle cell lymphoma, being effective against CNS disease.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter